Picture [LSA] – The Business Web Portal 650x89px
Document › Details

Garde, Damion [StatNews]. (8/30/17). "News: Pioneering Cancer Drug, Just Approved, to Cost $475,000 — and Analysts Say It’s a Bargain ".

Region Region United States (USA)
Organisations Organisation Novartis AG (NYSE: NVS)
  Group Novartis (Group)
  Organisation 2 FDA (US Food and Drug Administration)
  Group United States (govt)
Products Product Kymriah®
  Product 2 Chimeric Antigen Receptor technology (CAR technology)

Record changed: 2017-09-06


Picture [LSA] – The Business Web Portal 650x89px

More documents for Novartis (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BIO-Europe 2019 Partnering Report BEU2019 650x80px

» top